Thrombocytopenia following allogeneic hematopoietic stem cell transplantation is a usual
complication and can lead to high morbidity and mortality. New strategies, such as the use of …

Hematopoietic cell transplantation (HCT) is a well-established procedure that has become a
therapeutic mainstay for various hematological conditions. Prolonged thrombocytopenia …

Poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation (HCT) is a
serious complication with high morbidity and mortality. The reported incidence of PGF, its …

Thrombopoietin receptor agonists (TPO-RA) are currently indicated for the treatment of
chronic immune thrombocytopenia and relapsed refractory aplastic anemia. However, the off …

Allogeneic stem cell transplantation (alloSCT) is a potentially curative treatment for diseases
including myelodysplastic syndrome, leukaemia and lymphoma. However, the cost and …

Poor graft function (PGF) and secondary failure of platelet recovery (SFPR) are significant
causes of transplant related morbidity and mortality. Although thrombopoietin receptor …

Background/aim: Thrombocytopenia is a common complication following hematopoietic
stem cell transplantation (HSCT). Eltrombopag has been used in thrombocytopenia …

Hematopoietic cell transplantation (HCT) is a potentially curative therapy for patients with
high-risk malignant and nonmalignant conditions. Nevertheless, various post-allogeneic …

It is the most honorable medical award in South Korea. Two most distinguishable young
investigators are usually awarded from clinical and basic fields of medical society in Korea …

El trasplante alogénico de células progenitoras he-El complejo HLA consiste en más de 200
genes lomatopoyéticas (CPH) de sangre periférica o médula calizados en el cromosoma 6 …